[Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide].
D001786:Blood Glucose / Q000032:analysis; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005905:Glyburide / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000097:blood; D014044:Tolbutamide / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014044:Tolbutamide; D005905:Glyburide
Untersuchungen zur beta-cytotropen und antilipolytischen Wirkung von Grenzdosen des Tolbutamids und Glibenclamids.